Article Navigation

Back To Main Page


 

More Articles

Health Benefits of Olive Oil


by: Jean Fisher



Why should you use olive oil? Well there are several reasons. Substituting olive oil, a monounsaturated fat, for saturated fats or polyunsaturated fats can:
• Reduce blood pressure
• Inhibit the growth of some cancers
• Benefit people at risk for or with diabetes
• Lessen the severity of asthma and arthritis
• Actually help your body maintain a lower weight

HEALTHY HEART BENEFITS
Atherosclerosis, also called hardening of the arteries, occurs when particles of LDL cholesterol stick to the walls of the arteries. Eventually these particles build up and form plaque. This plaque narrows the blood vessels and increases the work load of the heart in an effort to get oxygenated blood to the entire body. The result can be a heart attack or stroke.
Olive oil is rich in monounsaturated fat and antioxidants like chlorophyll, carotenoids and vitamin E. Scientists have identified a compound in olive oil called oleuropein which prevents the LDL cholesterol from oxidizing. It is the oxidized cholesterol that sticks to the walls of the arteries and forms plaque. Replacing other fats in your diet with olive oil can significantly lower blood pressure and reduce the risk of heart attack.
CANCER INHIBITOR
A study published in the January 2005 issue of Annals of Oncology has identified oleic acid, a monounsaturated fatty acid found in olive oil, as having the ability to reduce the affect of an oncogene (a gene that will turn a host cell into a cancer cell). This particular oncogene is associated with the rapid growth of breast cancer tumors. The conclusion of the researchers was that oleic acid when combined with drug therapy encouraged the self-destruction of aggressive, treatment-resistant cancer cells thus destroying the cancer. Olive oil has been positively indicated in studies on prostate and endometrial cancers as well.
Unlike other fats, which are associated with a higher risk of colon cancer, olive oil helps protect the cells of the colon from carcinogens. A study published in the November 2003 issue of Food Chemistry Toxicology suggests that the antioxidants in olive oil reduce the amount of carcinogens formed when meat is cooked.
BLOOD SUGAR CONTROLLER
Diabetics or those at risk for diabetes are advised to combine a low-fat, high-carbohydrate diet with olive oil. Studies show this combination is superior at controlling blood sugar levels compared to a diet that consists entirely of low-fat meals. Adding olive oil is also linked to lower triglyceride levels. Many diabetics live with high triglyceride levels which put them at risk for heart disease.
ANTI-INFLAMMATORY PROPERTIES
The body uses the healthy fats in olive oil to produce natural anti-inflammatory agents. These anti-inflammatory agents can help reduce the severity of both arthritis and asthma. Uninflammed cell membranes are more fluid and better able to move healthy nutrients into the cells and move waste products out. A lower incidence of osteoporosis and dementia is found in areas where people consume large quantities of olive oil.
A FAT THAT HELPS YOU LOSE FAT
Sounds impossible, right? A study conducted on eight over-weight men published in the September 2003 issue of the British Journal of Nutrition yielded results that indicate a significant loss of body weight and fat mass can be achieved without increasing physical activity and making only one change in eating habits: the substitution of olive oil for saturated fats. The eight men were divided into two groups and for four weeks ate similar foods with the exception that the first group ate more saturated than unsaturated fats. The second group consumed the same number of calories as the first group, but the fats were mostly monounsaturated fat (olive oil). At the end of four weeks, the men from the second group were lighter and had a lower body-fat index than the men who ate the saturated fats.

IMPORTANT INFORMATION ON BUYING AND STORING OLIVE OIL
Exposure to light and heat can turn olive oil rancid. This destroys the healthy, antioxidant properties of the oil. Look for olive oil that is sold in darkly tinted bottles. Also, look carefully at the display in the grocery store. Are there glaring lights or sunny windows nearby? If so, you will want to check out some different stores. My favorite grocery store keeps the olive oil on the shelves closest to the floor and away from the fluorescent lights.
When you get home, find a dark, cool cupboard for storage. One suggestion is to pour some of the oil from the original container into a smaller container. The original container can be kept in the refrigerator for maximum protection. (The oil will become cloudy and more solid in the refrigerator.) The smaller container you select for your weekly supply of olive oil should be opaque and have a tight-sealing lid. Exposure to air is another enemy of the fragile antioxidants.
Confused about the different grades of olive oil? Extra-virgin olive oil is produced from the first pressing of the olives. It has the lightest flavor and contains the richest array of antioxidants. The next pressing of the olives produces fine virgin oil. Refined means that chemicals were used to extract the oil instead of pressing. Avoid refined olive oils. Pure olive oil is a blend of refined and virgin olive oils. I don’t recommend pure grade either. If you see the words cold pressed on a bottle of olive oil that means heat was not used when extracting the oil. Remember, heat destroys antioxidants, so cold pressed is a good thing.
One last thought on this subject. If you are considering switching to olive oil from other oils, you might be shocked when you first look at the differences in price. I’m a serious bargain hunter. I always buy generic and look for bulk discounts whenever possible. But even the most determined penny pincher understands that there are simply some things that are worth the extra money. Olive oil is one of them.





Latest Cancer News:



FDA panel votes against Xgeva for prostate cancer


A panel of cancer experts voted against a new use for Amgen's Xgeva in prostate cancer on Wednesday, saying the drug's ability to slow the spread of the disease did not translate into meaningful benefits for patients Breast cancer kills older women more often


NEW YORK (Reuters Health) - Breast cancer is often considered more deadly among younger women, but a new study shows older women are actually more likely to die of the disease. Researchers found that among women who had been diagnosed with a certain type of breast cancer, those over 75 years old were 63 percent more likely to die of the cancer than women younger than 65. "I suspect it's ... Breast cancer charity chases Komen defectors


As a prominent breast cancer researcher and activist, Susan Love is no stranger to the Susan G. Komen Foundation. Love runs a breast cancer research foundation that bears her name, and she organized the Army of Women , more than 360,000 women to whom breast cancer researchers can blast out requests for subjects. But the Komen Foundation is so entrenched in the world of breast cancer fundraising ... A Better Way to Spend Breast Cancer Funds?


We must move breast cancer advocacy to the next level, beyond screening for cancers that are already there, even beyond the cure, to finding the cause, writes Dr. Susan Love. Cancer-hit cricketer Yuvraj vows to return stronger


India's cancer-stricken World Cup hero Yuvraj Singh has vowed to return "stronger than ever" to competitive cricket, saying he was responding well to treatment in the United States. Doxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020


NEW YORK, Feb. 8, 2012  /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Doxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020 http://www.reportlinker.com/p0657184/Doxil/Caelyx-Ovarian-Cancer---Analysis-and-Forecasts-to-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=PathologyDoxil/Caelyx ... Triple Analysis: Lung Cancer, Angiogenesis and Cancer Vaccines


NEW YORK, Feb. 8, 2012  /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Triple Analysis: Lung Cancer, Angiogenesis and Cancer Vaccines http://www.reportlinker.com/p0284988/Triple-Analysis-Lung-Cancer-Angiogenesis-and-Cancer-Vaccines.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_MedicationThis ... Marian Regional Medical Center Receives CEO Cancer Gold Standard Accreditation


The CEO Roundtable on Cancer recently accredited Marian Regional Medical Center with the CEO Cancer Gold Standard? recognizing the hospital?s efforts to reduce the risk of cancer f Breast Cancer Drug May Weaken Bones, Study Finds


TUESDAY, Feb. 7 (HealthDay News) -- A drug used to prevent breast cancer in women at high risk for the disease appears to cause bone loss in some postmenopausal women, a new study finds. Marc Garnick Answers 6 Key Questions about Prostate Cancer


Marc Garnick Answers 6 Key Questions about Prostate Cancer Breast cancer kills older women more often - Fox News


News Image
Daily Mail

News Image
Breast cancer kills older women more often
Fox News
Print Email Share Comments Recommend Tweet Breast cancer is often considered more deadly among younger women, but a new study shows older women are actually more likely to die of the disease. Researchers found that among women who had been diagnosed ...
Breast cancer kills older women more often: studyReuters
Older women at breast cancer death riskTimes of India
Breast cancer screening 'no longer justified' and causes 7000 women a year to ...Daily Mail
ABC News -Tempo
all 100 news articles »
Insight: Komen charity under microscope for funding, science - Reuters


News Image
Los Angeles Times

News Image
Insight: Komen charity under microscope for funding, science
Reuters
By Sharon Begley and Janet Roberts | NEW YORK (Reuters) - The Susan G. Komen for the Cure charity defines its mission as finding a cure for breast cancer. In recent years, however, it has cut by nearly half the proportion of fund-raising dollars it ...
Komen Board's Wisdom Lost on Scott WalkerHuffington Post (blog)
Komen foundation shouldn't give any money to Planned ParenthoodBaltimore Sun
Komen executive quits as questions persistLos Angeles Times

all 3,873 news articles »
FDA panel votes against Xgeva for prostate cancer - The Associated Press


News Image
USA TODAY

News Image
FDA panel votes against Xgeva for prostate cancer
The Associated Press
WASHINGTON (AP) ? A panel of cancer experts voted against a new use for Amgen's Xgeva in prostate cancer on Wednesday, saying the drug's ability to slow the spread of the disease did not translate into meaningful benefits for patients The Food and ...
Amgen Fails to Win Advisory Panel Backing for Expanded Use of Cancer DrugBloomberg
FDA questions Amgen drug for prostate cancerUSA TODAY
FDA Panel Votes Against Expanding Use Of Amgen Drug XgevaFox Business

all 87 news articles »
Pa. woman gets probation for fake cancer claims - USA TODAY



News Image
Pa. woman gets probation for fake cancer claims
USA TODAY
(AP) ? A Pennsylvania woman who submitted nearly $100000 worth of fake cancer treatment insurance claims for herself and her husband must repay the money while she serves nearly nine years on probation. The Observer-Reporter of Washington, ...

and more »
program takes cancer patients on Road to Recovery - Chicago Daily Herald



News Image
program takes cancer patients on Road to Recovery
Chicago Daily Herald
By Elisabeth Mistretta Kathy Miller of Arlington Heights sat inside Northwest Community Hospital near her home two years ago, feeling beaten down from radiation and chemotherapy treatments to treat her stage-four throat cancer.
Winter adds to ordeal of cancer patientsSTLtoday.com

all 2 news articles »
Slow-Growing Prostate Cancer Is Still 'Real Cancer' - Medscape



News Image
Slow-Growing Prostate Cancer Is Still 'Real Cancer'
Medscape
February 8, 2012 ? Low-grade low-volume prostate cancer often grows very slowly, and men presenting with this diagnosis might never experience morbidity or mortality as a result of the condition. However, hearing the emotionally charged term "cancer" ...
Ask Dr. K: Hot flashes in men are caused by low testosteroneGreenville Daily Reflector

all 3 news articles »
DNA sequencing helps identify cancer cells for immune system attack - Washington University in St. Louis News


News Image
Washington University in St. Louis News

News Image
DNA sequencing helps identify cancer cells for immune system attack
Washington University in St. Louis News
By Michael C. Purdy DNA sequences from tumor cells can be used to direct the immune system to attack cancer, according to scientists at Washington University School of Medicine in St. Louis. The research, in mice, appears online Feb. 8 in Nature.

and more »
Montblanc Announces Unprecedented Partnership With Texas Children's Cancer Center - Sacramento Bee



News Image
Montblanc Announces Unprecedented Partnership With Texas Children's Cancer Center
Sacramento Bee
Montblanc and Texas Children's Cancer Center have joined together to support excellence in patient care, research and education to enhance the health and well being of our nation's children. To show personal commitment to this cause, Montblanc has ...
Texas Children's partners with Montblanc to raise fundsHouston Business Journal

all 8 news articles »
Breast cancer claims Purdue astronaut Janice Voss, 55 - Journal and Courier


News Image
RedOrbit

News Image
Breast cancer claims Purdue astronaut Janice Voss, 55
Journal and Courier
Astronaut Janice E. Voss, a Purdue University graduate and one of the few women launched into space, died Monday in Scottsdale, Ariz., after a battle with breast cancer. She was 55. Voss was part of five space shuttle missions, spending a total of 49 ...
Cancer Claims Five-Time Shuttle AstronautDiscovery News
Janice Voss, Shuttle Astronaut, Dies of Cancer at 55ThirdAge
NASA Astronaut Janice Voss Loses Battle Against Breast CancerRedOrbit
WIFR -French Tribune -Boston.com
all 190 news articles »
Roche Breast Cancer Drug Pertuzumab Gets FDA Priority Review - Fox Business


News Image
Insciences Organisation

News Image
Roche Breast Cancer Drug Pertuzumab Gets FDA Priority Review
Fox Business
VX) experimental breast cancer drug pertuzumab, opening the way for a launch as early as 2012 for a product the Swiss company hopes can contain damage from lost sales when top seller Herceptin loses patent protection in a few years' time.
Roche breast cancer drug gets FDA priority reviewMarketWatch
FDA rewards Roche with priority review for blockbuster cancer drugFierceBiotech
FDA will speed up review of Roche cancer drugCBS News
PMLiVE -HemOncToday
all 53 news articles »

 



Home | Resource Links | Contact Us
Copyright © 2006 CancerAdvice.org